Evidence map›Paper›PMID 40922855›Full record

ArticleCureus2025

Kounis Syndrome Triggered by Intravenous Co-Amoxiclav: A Case of Transient ST Elevation in the Context of Anaphylaxis.

Yusif Shakanti, Abdulrahman Irhouma, Ahmed Hassan

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yusif ShakantiEmergency Medicine, Stockport NHS Foundation Trust, Stockport, GBR.
Abdulrahman IrhoumaGeneral Medicine, Manchester University NHS Foundation Trust, Manchester, GBR.
Ahmed HassanEmergency Medicine, Stockport NHS Foundation Trust, Stockport, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kounis syndrome, also known as allergic myocardial infarction, is a rare but potentially life-threatening condition in which acute coronary events are triggered by an allergic reaction. The pathophysiology involves mast cell degranulation and the release of inflammatory mediators such as histamine, leukotrienes, and platelet-activating factor, leading to coronary vasospasm, myocardial ischemia, or infarction. We present the case of a female patient in her 80s with no prior history of coronary artery disease who developed anaphylaxis shortly after intravenous administration of co-amoxiclav in the emergency department. She had no documented allergy to penicillin or prior hypersensitivity reactions. Within minutes, she experienced an acute onset of dyspnoea, hypotension (systolic BP dropped to 70 mmHg), and widespread urticaria. The patient was treated promptly with intramuscular epinephrine (0.5 mg), leading to hemodynamic stabilization and resolution of ECG changes. She was admitted for observation and recovered without further cardiac complications. Simultaneously, her ECG done within 15 minutes of the onset of the allergic reaction showed new ST-segment elevation in the inferior leads and anterior leads. She went on to have serial ECGs performed to monitor disease progression, and the ST elevations showed partial resolution within 30 minutes following treatment, with complete resolution 12 hours later. High-sensitivity cardiac troponin I was initially 10 ng/L (0-54 ng/L) and remained essentially unchanged at 23 ng/L after 12 hours, suggesting a non-dynamic pattern on serial monitoring. Echocardiography showed normal left ventricular function without regional wall motion abnormalities. Coronary angiography was not performed, as the clinical presentation, rapid normalization of ECG changes, normal echocardiographic findings, and non-dynamic cardiac biomarkers strongly supported a vasospastic rather than obstructive coronary pathology. This case illustrates the diagnostic challenge of differentiating Kounis syndrome from typical acute coronary syndromes, particularly in older adults. Recognizing the allergic trigger and observing the transient nature of ECG changes can help avoid unnecessary invasive procedures. Management should focus on treating the allergic reaction, which may be sufficient to reverse myocardial involvement. Kounis syndrome should be considered in patients presenting with ECG changes following an allergic reaction. Treatment should prioritize the management of the hypersensitivity response, which may in fact reverse cardiac involvement without the need for invasive cardiac procedures.

Indexed as

allergy and anaphylaxisco-amoxiclavintramuscular epinephrine complicationskounis syndrome (ks)st-elevation myocardial infarction (stemi)

Identifiers

PMID40922855
PMCPMC12414535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.